Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
18
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Kelly Timothy P | Chief Technology Officer | 7 | $0 | $18.2K | 2026-02-25 |
| Albertson Tina M. | Chief Medical Officer | 6 | $0 | $2.1K | 2026-02-24 |
| Khan Ruhi Ahmad | Chief Business Officer | 11 | $0 | $18.4K | 2026-02-24 |
| MCCLUNG BARBARA G | Chief Legal Officer | 22 | $41.3K | $18.4K | 2026-02-24 |
| Richardson-Heron Dara | Director | 5 | $0 | $0 | 2026-02-20 |
| Zheng Ran | Director | 6 | $0 | $0 | 2026-02-20 |
| Whiting Nancy | Director | 7 | $0 | $0 | 2026-02-20 |
| Ryali Sriram | Chief Financial Officer | 4 | $24.7K | $0 | 2026-02-20 |
| JOHNSON DAVID LEE | Director | 5 | $0 | $0 | 2026-02-20 |
| Sacks Natalie | Director | 5 | $0 | $0 | 2026-02-20 |
| Haurwitz Rachel E. | President and CEO | 19 | $20.4K | $0 | 2026-02-20 |
| Braunstein Scott | Director | 5 | $0 | $0 | 2026-02-20 |
| GUGGENHIME ANDREW | Director | 5 | $0 | $0 | 2026-02-20 |
| Kanner Steven | Chief Scientific Officer | 28 | $220.8K | $490.1K | 2025-02-21 |
| Fischesser Ryan | VP of Finance and Controller | 24 | $37.3K | $108.0K | 2024-11-20 |
| O'Byrne Jason | Chief Financial Officer | 6 | $0 | $0 | 2024-02-20 |
| Rizvi Syed Ali-aamir | Chief Medical Officer | 4 | $0 | $35.5K | 2023-02-21 |
| FMR LLC | Other | 8 | $0 | $0 | 2021-07-27 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Kelly Timothy P | Chief Technology Officer | S Sale | 2026-02-25 | 2026-02-27 | 6,228 | $1.93 | $12.0K | 73,125 | SEC↗ |
| Albertson Tina M. | Chief Medical Officer | S Sale | 2026-02-24 | 2026-02-24 | 1,066 | $1.96 | $2.1K | 68,523 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | S Sale | 2026-02-24 | 2026-02-24 | 6,938 | $1.96 | $13.6K | 104,998 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | S Sale | 2026-02-24 | 2026-02-24 | 6,938 | $1.96 | $13.6K | 481,564 | SEC↗ |
| Kelly Timothy P | Chief Technology Officer | S Sale | 2026-02-24 | 2026-02-24 | 3,147 | $1.96 | $6.2K | 79,353 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | A Award deriv | 2026-02-20 | 2026-02-20 | 682,500 | — | $0 | 682,500 | SEC↗ |
| Ryali Sriram | Chief Financial Officer | A Award deriv | 2026-02-20 | 2026-02-20 | 247,500 | — | $0 | 247,500 | SEC↗ |
| Braunstein Scott | Director | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GUGGENHIME ANDREW | Director | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| JOHNSON DAVID LEE | Director | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Richardson-Heron Dara | Director | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Sacks Natalie | Director | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Zheng Ran | Director | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Albertson Tina M. | Chief Medical Officer | A Award deriv | 2026-02-20 | 2026-02-24 | 247,500 | — | $0 | 247,500 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award deriv | 2026-02-20 | 2026-02-24 | 202,500 | — | $0 | 202,500 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | A Award deriv | 2026-02-20 | 2026-02-24 | 202,500 | — | $0 | 202,500 | SEC↗ |
| Kelly Timothy P | Chief Technology Officer | A Award deriv | 2026-02-20 | 2026-02-24 | 202,500 | — | $0 | 202,500 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | A Award | 2026-02-20 | 2026-02-20 | 151,700 | — | $0 | 447,150 | SEC↗ |
| Ryali Sriram | Chief Financial Officer | A Award | 2026-02-20 | 2026-02-20 | 55,000 | — | $0 | 72,360 | SEC↗ |
| Albertson Tina M. | Chief Medical Officer | A Award | 2026-02-20 | 2026-02-24 | 55,000 | — | $0 | 69,589 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award | 2026-02-20 | 2026-02-24 | 45,000 | — | $0 | 111,936 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | A Award | 2026-02-20 | 2026-02-24 | 45,000 | — | $0 | 488,502 | SEC↗ |
| Kelly Timothy P | Chief Technology Officer | A Award | 2026-02-20 | 2026-02-24 | 45,000 | — | $0 | 82,500 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | P Buy | 2025-03-14 | 2025-03-17 | 20,000 | $1.02 | $20.4K | 3,369,395 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | S Sale | 2025-02-21 | 2025-02-21 | 3,564 | $1.35 | $4.8K | 431,556 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | S Sale | 2025-02-21 | 2025-02-21 | 3,564 | $1.35 | $4.8K | 66,936 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | S Sale | 2025-02-21 | 2025-02-21 | 3,564 | $1.35 | $4.8K | 443,502 | SEC↗ |
| Braunstein Scott | Director | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| GUGGENHIME ANDREW | Director | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| JOHNSON DAVID LEE | Director | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Richardson-Heron Dara | Director | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Sacks Natalie | Director | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Zheng Ran | Director | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | A Award deriv | 2025-02-20 | 2025-02-21 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Kelly Timothy P | Chief Technology Officer | A Award deriv | 2025-02-20 | 2025-02-21 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award deriv | 2025-02-20 | 2025-02-21 | 170,000 | — | $0 | 170,000 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | A Award deriv | 2025-02-20 | 2025-02-21 | 170,000 | — | $0 | 170,000 | SEC↗ |
| Albertson Tina M. | Chief Medical Officer | A Award deriv | 2025-02-20 | 2025-02-21 | 66,137 | — | $0 | 66,137 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | A Award deriv | 2025-02-20 | 2025-02-21 | 618,250 | — | $0 | 618,250 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | A Award | 2025-02-20 | 2025-02-21 | 37,500 | — | $0 | 435,120 | SEC↗ |
| Kelly Timothy P | Chief Technology Officer | A Award | 2025-02-20 | 2025-02-21 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award | 2025-02-20 | 2025-02-21 | 37,500 | — | $0 | 70,500 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | A Award | 2025-02-20 | 2025-02-21 | 37,500 | — | $0 | 447,066 | SEC↗ |
| Albertson Tina M. | Chief Medical Officer | A Award | 2025-02-20 | 2025-02-21 | 14,589 | — | $0 | 14,589 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | A Award | 2025-02-20 | 2025-02-21 | 136,750 | — | $0 | 295,450 | SEC↗ |
| Ryali Sriram | Chief Financial Officer | P Buy | 2025-01-29 | 2025-01-30 | 17,360 | $1.42 | $24.7K | 17,360 | SEC↗ |
| Ryali Sriram | Chief Financial Officer | A Award deriv | 2025-01-10 | 2025-01-10 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | A Award | 2024-11-20 | 2024-11-22 | 25,000 | — | $0 | 118,854 | SEC↗ |
| Albertson Tina M. | Chief Medical Officer | A Award deriv | 2024-08-19 | 2024-08-20 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Braunstein Scott | Director | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| GUGGENHIME ANDREW | Director | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| JOHNSON DAVID LEE | Director | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| Richardson-Heron Dara | Director | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| Sacks Natalie | Director | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| Zheng Ran | Director | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | A Award deriv | 2024-02-20 | 2024-02-22 | 153,000 | — | $0 | 153,000 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | A Award deriv | 2024-02-20 | 2024-02-22 | 546,950 | — | $0 | 546,950 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award deriv | 2024-02-20 | 2024-02-22 | 153,000 | — | $0 | 153,000 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | A Award deriv | 2024-02-20 | 2024-02-22 | 153,000 | — | $0 | 153,000 | SEC↗ |
| O'Byrne Jason | Chief Financial Officer | A Award deriv | 2024-02-20 | 2024-02-22 | 153,000 | — | $0 | 153,000 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | A Award | 2024-02-20 | 2024-02-22 | 33,000 | — | $0 | 387,037 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | A Award | 2024-02-20 | 2024-02-22 | 118,700 | — | $0 | 158,700 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award | 2024-02-20 | 2024-02-22 | 33,000 | — | $0 | 33,000 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | A Award | 2024-02-20 | 2024-02-22 | 33,000 | — | $0 | 409,566 | SEC↗ |
| O'Byrne Jason | Chief Financial Officer | A Award | 2024-02-20 | 2024-02-22 | 33,000 | — | $0 | 59,224 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise deriv | 2024-02-06 | 2024-02-08 | 30,577 | — | $0 | 21,623 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise | 2024-02-06 | 2024-02-08 | 30,577 | $2.69 | $82.3K | 354,037 | SEC↗ |
| Kelly Timothy P | Chief Technology Officer | A Award deriv | 2024-01-08 | 2024-01-09 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise deriv | 2023-06-08 | 2023-06-09 | 10,000 | — | $0 | 96,350 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise | 2023-06-08 | 2023-06-09 | 10,000 | $2.96 | $29.6K | 40,000 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise deriv | 2023-03-20 | 2023-03-22 | 10,000 | — | $0 | 106,350 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise | 2023-03-20 | 2023-03-22 | 10,000 | $2.96 | $29.6K | 30,000 | SEC↗ |
| JOHNSON DAVID LEE | Director | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| O'Byrne Jason | Chief Financial Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 131,000 | — | $0 | 131,000 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Zheng Ran | Director | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Rizvi Syed Ali-aamir | Chief Medical Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 131,000 | — | $0 | 131,000 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 131,000 | — | $0 | 131,000 | SEC↗ |
| GUGGENHIME ANDREW | Director | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Braunstein Scott | Director | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Sacks Natalie | Director | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 131,000 | — | $0 | 131,000 | SEC↗ |
| Richardson-Heron Dara | Director | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | A Award deriv | 2023-02-21 | 2023-02-23 | 131,000 | — | $0 | 131,000 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | A Award deriv | 2023-02-21 | 2023-02-23 | 510,500 | — | $0 | 510,500 | SEC↗ |
| Rizvi Syed Ali-aamir | Chief Medical Officer | S Sale | 2023-01-19 | 2023-01-20 | 5,627 | $6.31 | $35.5K | 59,373 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise deriv | 2022-12-02 | 2022-12-02 | 21,401 | $2.69 | $57.6K | 52,200 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise | 2022-12-02 | 2022-12-02 | 21,401 | $2.69 | $57.6K | 323,460 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise deriv | 2022-10-06 | 2022-10-07 | 2,839 | — | $0 | 1,704 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise deriv | 2022-10-06 | 2022-10-07 | 2,839 | — | $0 | 15,337 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | S Sale | 2022-10-06 | 2022-10-07 | 10,000 | $10.80 | $108.0K | 110,366 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise | 2022-10-06 | 2022-10-07 | 2,839 | $4.11 | $11.7K | 116,044 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise | 2022-10-06 | 2022-10-07 | 2,839 | $2.69 | $7.6K | 113,205 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | M Exercise deriv | 2022-09-15 | 2022-09-16 | 27,518 | — | $0 | 47,318 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | M Exercise deriv | 2022-09-15 | 2022-09-16 | 77 | — | $0 | 0 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | M Exercise | 2022-09-15 | 2022-09-16 | 27,518 | $2.69 | $74.0K | 376,566 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | M Exercise | 2022-09-15 | 2022-09-16 | 77 | $2.69 | $207 | 349,048 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise deriv | 2022-08-25 | 2022-08-26 | 43,248 | — | $0 | 73,601 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise | 2022-08-25 | 2022-08-26 | 43,248 | $2.69 | $116.3K | 345,307 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | S Sale | 2022-08-25 | 2022-08-26 | 43,248 | $11.22 | $485.2K | 302,059 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award deriv | 2022-08-22 | 2022-08-24 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | A Award | 2022-08-22 | 2022-08-24 | 4,848 | — | $0 | 120,366 | SEC↗ |
| JOHNSON DAVID LEE | Director | A Award deriv | 2022-05-18 | 2022-05-18 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise deriv | 2022-05-13 | 2022-05-17 | 68,306 | — | $0 | 3,534 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise deriv | 2022-05-13 | 2022-05-17 | 6,114 | — | $0 | 116,849 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise | 2022-05-13 | 2022-05-17 | 68,306 | $1.81 | $123.6K | 295,945 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise | 2022-05-13 | 2022-05-17 | 6,114 | $2.69 | $16.4K | 302,059 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise deriv | 2022-05-09 | 2022-05-10 | 10,000 | — | $0 | 116,350 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise | 2022-05-09 | 2022-05-10 | 10,000 | $2.96 | $29.6K | 20,000 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise deriv | 2022-05-05 | 2022-05-06 | 1,136 | — | $0 | 4,543 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise deriv | 2022-05-05 | 2022-05-06 | 1,138 | — | $0 | 18,176 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise | 2022-05-05 | 2022-05-06 | 1,136 | $2.69 | $3.1K | 114,380 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise | 2022-05-05 | 2022-05-06 | 1,138 | $4.11 | $4.7K | 115,518 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise deriv | 2022-03-15 | 2022-03-17 | 1,138 | — | $0 | 19,314 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise deriv | 2022-03-15 | 2022-03-17 | 1,136 | — | $0 | 5,679 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise | 2022-03-15 | 2022-03-17 | 1,138 | $4.11 | $4.7K | 113,244 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | M Exercise | 2022-03-15 | 2022-03-17 | 1,136 | $2.69 | $3.1K | 112,106 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise deriv | 2022-03-04 | 2022-03-07 | 1,549 | — | $0 | 230,365 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise deriv | 2022-03-04 | 2022-03-07 | 9,171 | — | $0 | 122,963 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise | 2022-03-04 | 2022-03-07 | 1,549 | $4.11 | $6.4K | 227,639 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | M Exercise | 2022-03-04 | 2022-03-07 | 9,171 | $2.69 | $24.7K | 226,090 | SEC↗ |
| O'Byrne Jason | Chief Financial Officer | M Exercise deriv | 2022-02-08 | 2022-02-08 | 24,336 | — | $0 | 412,865 | SEC↗ |
| O'Byrne Jason | Chief Financial Officer | M Exercise | 2022-02-08 | 2022-02-08 | 24,336 | $4.11 | $100.0K | 24,336 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise deriv | 2022-01-26 | 2022-05-10 | 10,000 | — | $0 | 126,350 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise | 2022-01-26 | 2022-05-10 | 10,000 | $2.96 | $29.6K | 10,000 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise deriv | 2022-01-26 | 2022-01-27 | 10,000 | — | $0 | 126,350 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | M Exercise | 2022-01-26 | 2022-01-27 | 10,000 | $2.96 | $29.6K | 3,359,395 | SEC↗ |
| Rizvi Syed Ali-aamir | Chief Medical Officer | A Award deriv | 2022-01-25 | 2022-01-25 | 161,250 | — | $0 | 161,250 | SEC↗ |
| Rizvi Syed Ali-aamir | Chief Medical Officer | A Award | 2022-01-25 | 2022-01-25 | 60,000 | — | $0 | 65,000 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | X Exercise deriv | 2022-01-11 | 2022-01-12 | 6,818 | — | $0 | 20,452 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | X Exercise deriv | 2022-01-11 | 2022-01-12 | 569 | — | $0 | 6,815 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | P Buy | 2022-01-11 | 2022-01-12 | 569 | $2.69 | $1.5K | 102,264 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | P Buy | 2022-01-11 | 2022-01-12 | 6,818 | $4.11 | $28.0K | 109,082 | SEC↗ |
| Braunstein Scott | Director | A Award deriv | 2021-12-20 | 2021-12-21 | 27,500 | — | $0 | 27,500 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | X Exercise deriv | 2021-12-20 | 2021-12-21 | 1,136 | — | $0 | 7,384 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | A Award deriv | 2021-12-20 | 2021-12-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GUGGENHIME ANDREW | Director | A Award deriv | 2021-12-20 | 2021-12-21 | 27,500 | — | $0 | 27,500 | SEC↗ |
| Haurwitz Rachel E. | President and CEO | A Award deriv | 2021-12-20 | 2021-12-21 | 411,000 | — | $0 | 411,000 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | A Award deriv | 2021-12-20 | 2021-12-21 | 147,000 | — | $0 | 147,000 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | A Award deriv | 2021-12-20 | 2021-12-21 | 147,000 | — | $0 | 147,000 | SEC↗ |
| O'Byrne Jason | Chief Financial Officer | A Award deriv | 2021-12-20 | 2021-12-21 | 147,000 | — | $0 | 147,000 | SEC↗ |
| Sacks Natalie | Director | A Award deriv | 2021-12-20 | 2021-12-21 | 27,500 | — | $0 | 27,500 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2021-12-20 | 2021-12-21 | 13,750 | — | $0 | 13,750 | SEC↗ |
| Zheng Ran | Director | A Award deriv | 2021-12-20 | 2021-12-21 | 13,750 | — | $0 | 13,750 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2021-12-20 | 2021-12-22 | 13,060 | — | $0 | 13,060 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | P Buy | 2021-12-20 | 2021-12-21 | 1,136 | $2.69 | $3.1K | 101,695 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | X Exercise deriv | 2021-12-07 | 2021-12-08 | 6,115 | — | $0 | 74,836 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | X Exercise deriv | 2021-12-07 | 2021-12-08 | 12 | — | $0 | 77 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | P Buy | 2021-12-07 | 2021-12-08 | 6,115 | $2.69 | $16.4K | 348,971 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | P Buy | 2021-12-07 | 2021-12-08 | 12 | $2.69 | $32 | 342,856 | SEC↗ |
| Khan Ruhi Ahmad | Chief Business Officer | A Award deriv | 2021-11-15 | 2021-11-16 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Richardson-Heron Dara | Director | A Award deriv | 2021-11-11 | 2021-11-15 | 44,000 | — | $0 | 44,000 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | X Exercise deriv | 2021-10-20 | 2021-10-21 | 43 | — | $0 | 89 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | X Exercise deriv | 2021-10-20 | 2021-10-21 | 9,176 | — | $0 | 80,951 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | P Buy | 2021-10-20 | 2021-10-21 | 9,176 | $2.69 | $24.7K | 342,801 | SEC↗ |
| MCCLUNG BARBARA G | Chief Legal Officer | P Buy | 2021-10-20 | 2021-10-21 | 43 | $2.69 | $116 | 342,844 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | X Exercise deriv | 2021-10-12 | 2021-10-13 | 14,614 | — | $0 | 132,134 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | X Exercise deriv | 2021-10-12 | 2021-10-13 | 99,548 | — | $0 | 71,840 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | X Exercise deriv | 2021-10-12 | 2021-10-13 | 698 | — | $0 | 4,879 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | P Buy | 2021-10-12 | 2021-10-13 | 698 | $1.81 | $1.3K | 200,417 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | P Buy | 2021-10-12 | 2021-10-13 | 14,614 | $2.69 | $39.3K | 215,031 | SEC↗ |
| Kanner Steven | Chief Scientific Officer | P Buy | 2021-10-12 | 2021-10-13 | 99,548 | $1.81 | $180.2K | 199,719 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | X Exercise deriv | 2021-10-11 | 2021-10-12 | 1,746 | — | $0 | 8,520 | SEC↗ |
| Fischesser Ryan | VP of Finance and Controller | P Buy | 2021-10-11 | 2021-10-12 | 1,746 | $2.69 | $4.7K | 100,559 | SEC↗ |
| Zheng Ran | Director | A Award deriv | 2021-10-01 | 2021-10-04 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Whiting Nancy | Director | A Award deriv | 2021-09-08 | 2021-09-09 | 44,000 | — | $0 | 44,000 | SEC↗ |
| FMR LLC | Other | C Conversion deriv | 2021-07-27 | 2021-07-29 | 588,794 | — | $0 | 0 | SEC↗ |
| FMR LLC | Other | C Conversion deriv | 2021-07-27 | 2021-07-29 | 9,666 | — | $0 | 0 | SEC↗ |
| FMR LLC | Other | C Conversion deriv | 2021-07-27 | 2021-07-29 | 805,707 | — | $0 | 0 | SEC↗ |
| FMR LLC | Other | C Conversion deriv | 2021-07-27 | 2021-07-29 | 423,823 | — | $0 | 0 | SEC↗ |
| FMR LLC | Other | C Conversion | 2021-07-27 | 2021-07-29 | 770,510 | — | $0 | 770,510 | SEC↗ |
| FMR LLC | Other | C Conversion | 2021-07-27 | 2021-07-29 | 1,070,427 | — | $0 | 1,840,937 | SEC↗ |
| FMR LLC | Other | C Conversion | 2021-07-27 | 2021-07-29 | 17,572 | — | $0 | 17,572 | SEC↗ |
| FMR LLC | Other | C Conversion | 2021-07-27 | 2021-07-29 | 1,464,775 | — | $0 | 1,464,775 | SEC↗ |